Related Experiment Video
Updated: Apr 21, 2026

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors
Jubilee Brown1, Michael Friedlander, Floor J Backes
1*University of Texas MD Anderson Cancer Center, Houston, TX (Gynecologic Oncology Group [GOG]); †Prince of Wales Hospital, Sydney, Australia (Australia and New Zealand Gynecological Oncology Group [ANZGOG]); ‡The Ohio State University, Columbus, OH (GOG); §Kliniken Essen-Mitte, Essen, Germany (AGO); ∥University of Louisville, Louisville, KY (GOG); ¶Institut Curie, Hôpital Rene Huguenin, Saint Cloud, France (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [GINECO]); #Fondazione IRCCS National Cancer Institute of Milan, Italy (Multicentre Italian Trials in Ovarian Cancer); **Tampere University Hospital, Tampere, Finland (Nordic Society of Gynaecological Oncology); ††Seoul National University College of Medicine, Seoul, Korea (Korean Gynecologic Oncology Group); ‡‡The University of Chicago, Chicago, IL (GOG); and §§Charing Cross Hospital, London, UK (Medical Research Council/National Cancer Research Institute [MRC NCRI]).
Malignant ovarian germ cell tumors are highly curable in most women, with fertility-sparing options available. Global consensus guidelines now standardize diagnosis and management for improved patient outcomes.
Area of Science:
- Gynecology
- Oncology
- Pathology
Background:
- Malignant ovarian germ cell tumors (OGCTs) predominantly affect young women and girls.
- Early-stage disease is common, but advanced stages occur in about 30% of patients.
- OGCTs are typically chemosensitive, facilitating fertility-sparing surgical approaches.
Purpose of the Study:
- To establish worldwide consensus guidelines for the diagnosis and management of OGCTs.
- To summarize current practice standards validated globally.
- To promote collaborative efforts for optimal treatment of these rare tumors.
Main Methods:
- Development of consensus recommendations based on existing literature and expert agreement.
- Synthesis of data from cooperative groups worldwide.
- Review of previously published summary documents and individual publications.
Main Results:
- Most women with OGCTs have curable disease with excellent survival rates.
- Treatment offers manageable morbidity, benefiting from advances over four decades.
- Fertility-sparing surgery is feasible for most patients, ensuring a high cure rate.
Conclusions:
- Standardized international guidelines are crucial for effective clinical trial design and patient accrual.
- Collaborative, multidisciplinary approaches ensure optimal treatment for rare OGCTs.
- Adherence to global practice standards improves patient outcomes and survivability.
Related Concept Videos
Treatment Resistent Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Treatment Resistant Cancers

